Final Program [International AIDS Society (11th: 1996: Vancouver, Canada)]

VENUE ROOM TRACK SESSION NO. TIME / SESSION PATHWAYS
B ay I 209 Track A: Basic Science
- - Exhibit Poster DiscuSSion:
& Poster Tropism and Infectivity
Hall Moderators:
Yoshivuki Nagai, Japan / Bruno Polliotti, USA...............................................................................................................................................................................................................................................
Tu.A. 140
HUMAN HEMATOPOIETIC PROGENITOR CELLS BECOME SUSCEPTIBLE TO HUMAN IMMUNODEFICIENCYVIRUS TYPE-I
INFECTION AFTER EXPOSURE TO HUMAN HERPES VIRUS 6
Furlini, G, Re MC,Vignoli M, Ramazzotti E, La Placa M. Institute of Microbiology University of Bologna, Bologna, Italy...............................................................................................................................................................................................................................................
Tu.A. 141
HIV AND SIV DOWN-REGULATE THEIR OWN INFECTIVITY POTENTIAL THROUGH VIRION SURFACE SIALYLATION
Nagai,Yoshiyuki, Hu H, Moriya C, Xin X, Hasan M, ShiodaT Institute of Medical Science, University ofTokyo,Tokyo, Japan................................................................................................................................................................................................................................................
Tu.A. 142
HIV-I REPLICATION IN EPITHELIAL INTESTINAL CELLS
Chenine, Agnes Laurence, Sanchez G, Lecontel C, Godard C, Chermann JC, Hirsch I. INSERM U322, Unit6 de Recherches sur les
Retrovirus et Maladies Associees, Marseille, France................................................................................................................................................................................................................................................
Tu.A. 143
CAPILLARY ENDOTHELIAL CELLS DERIVED FROM HUMAN BRAIN TUMORS ARE PERMISSIVE FOR HIV-INFECTION
Oltrogge, ji, von Briesen, Hageni, Engelhardt B3, Pereda-Fernandez CI,Woelki U2, Schlote W2, Lorenz R2, Rubsamen-Waigmann H4,
Unger RE'. 'Chemotherapeutical Research Institute, George-Speyer-Haus; 2University of Frankfurt, Frankfurt; 3Max-Planck-lnstitute
Physiology & Clinical Research, Bad Nauheim; 4Bayer AG, Germany...............................................................................................................................................................................................................................................
Tu.A. 144
INTERACTION OF HIV AND SIV ENVELOPE GLYCOPROTEINS WITH LIPIDS AND GLYCOLIPIDS
Barharoui, Elmostafal, Moulard M2, Elmeskini R2, Canarelli S2, Montagnier L3. IUniversity Paul-SabatierToulouse; 2Universite Aix-Marseille
II; 31nstitut Pasteur, France.,...............................................................................................................................................................................................................................................
Tu.A. 145
v INFECTIVITY OF DIFFERENT HIV-I STRAINS IN THE HUMAN PLACENTA IN VITRO
o Polliotti, Bruno MI, Demeter L2, Subbarao S3, Keesling S4, Lee GR4, Caba J4, Panigel M4, Nahmias AJ4, Reichman R2, Miller RKI. IDept. of
S Ob/Gyn, Env. Medicine; 2Medicine; 3University of Rochester, NY NCID, CDC; 4Dept. of Pediatric Infectious Diseases, Emory University
> Atlanta, GA, USA.
/...............................................................................................................................................................................................................................................
Tu.A. 146
c KINETICS OF HIV-I TRANSCRIPTION IN CELLS OF LYMPHOCYTES AND MONOCYTE-MACROPHAGE LINEAGE
0
O Vellani, Nina N, MoT Leung B, Cassol S. BC Centre for Excellence in HIV/AIDS, St. Pauls Hospital,Vancouver BC, Canada.
C
a)
o
C
U
c
O
u
a)
C

X

120